Live feed16:08:05·100dINSIDERFilingvia QuantisnowEVP, Chief Commercial Officer Callos Andrew was granted 33,966 shares, increasing direct ownership by 71% to 81,824 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CYTK· Cytokinetics IncorporatedHealth CareOriginal source
